Genelux (GNLX) Common Equity (2022 - 2026)

Genelux's Common Equity history runs 5 years deep, the most recent figure standing at $22.9 million for Q1 2026.

• In Q1 2026, Common Equity fell 23.2% year-over-year to $22.9 million; the TTM figure through Mar 2026 stood at $22.9 million (down 23.2% YoY), while the FY2025 annual figure was $11.5 million, down 56.06% from the prior year.
• Common Equity was $22.9 million for Q1 2026 at Genelux, up from $11.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $37.7 million in Q2 2024 to a low of -$35.8 million in Q4 2022.
• Historically, Common Equity has averaged $14.6 million across 5 years, with a median of $22.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Common Equity jumped 460.54% in 2024, then tumbled 56.06% in 2025.
• A 5-year view of Common Equity shows it stood at -$35.8 million in 2022, then jumped by 154.42% to $19.5 million in 2023, then jumped by 34.93% to $26.3 million in 2024, then sank by 56.06% to $11.5 million in 2025, then soared by 98.55% to $22.9 million in 2026.
• The last three Common Equity figures came in at $22.9 million (Q1 2026), $11.5 million (Q4 2025), and $18.6 million (Q3 2025), per Business Quant data.